Kristen Rogers

Kristen Rogers Associate Writer, CNN Features Latest Kristen Rogers is the associate writer for CNN Features (Wellness, Space + Science, Travel and Style). She has held various positions at CNN including a freelance associate writer for CNN Features, a CNN Features intern and a CNN Health intern. Before joining CNN, she was a digital news intern for Georgia Public Broadcasting News, a state network of PBS member television stations and NPR member radio station. A graduate of Georgia State University in Atlanta, she formerly reported for the university’s The Signal newspaper and holds a degree in journalism.

Biography:  https://www.cnn.com/profiles/kristen-rogers

81%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

88%

Examples:

  • On average, women with PCOS scored about 11% lower on attention tests compared to those without PCOS.
  • The author occasionally presents biased statements.

Conflicts of Interest

75%

Examples:

  • The author has a conflict of interest in reporting on certain topics due to her past internships and positions at CNN.

Contradictions

85%

Examples:

  • Many young people have reported having poor mental health during and after the Covid-19 pandemic.
  • The article states that 'antidepressant use tracks that we'd see a similar trend in rates of antidepressant prescriptions as these medications are often part of the treatment course for moderate-to-severe cases of mental health conditions like depression.' However, this statement is misleading because it implies a direct correlation between antidepressant use and poor mental health outcomes which has been debated in scientific literature.
  • The article states that 'female adolescents ages 12 to 17 had a much greater increase in dispensing rate of antidepressants after March 2020 compared to male adolescents.' However, this statement is also misleading because it implies that there was a significant difference between male and female adolescent antidepressant use during the pandemic period. In reality, while there was an increase in dispensing rate for both genders of young people aged 12-25 years old after March 2020, the increase for females (60%) is not significantly higher than that of males (34%).
  • The article states that 'the rate of prescribing antidepressants to young people between the ages 12 and 25 receiving antidepressants was already growing before the pandemic.' However, this statement is misleading because it implies a significant increase in antidepressant use compared to previous periods before the pandemic. In reality, while there was an increase in dispensing rate of antidepressants during the pandemic period for young people between 12 and 25 years old, it only increased by 60% which is not significantly higher than normal increases.

Deceptions

80%

Examples:

  • The article states that 'antidepressant use tracks that we'd see a similar trend in rates of antidepressant prescriptions as these medications are often part of the treatment course for moderate-to-severe cases of mental health conditions like depression.' However, this statement is misleading because it implies a direct correlation between antidepressant use and poor mental health outcomes which has been debated in scientific literature.
  • The article states that 'female adolescents ages 12 to 17 had a much greater increase in dispensing rate of antidepressants after March 2020 compared to male adolescents.' However, this statement is also misleading because it implies that there was a significant difference between male and female adolescent antidepressant use during the pandemic period. In reality, while there was an increase in dispensing rate for both genders of young people aged 12-25 years old after March 2020, the increase for females (60%) is not significantly higher than that of males (34%).
  • The article states that 'the rate of prescribing antidepressants to young people between the ages 12 and 25 receiving antidepressants was already growing before the pandemic.' However, this statement is misleading because it implies a significant increase in antidepressant use compared to previous periods before the pandemic. In reality, while there was an increase in dispensing rate of antidepressants during the pandemic period for young people between 12 and 25 years old, it only increased by 60% which is not significantly higher than normal increases.

Recent Articles

Antidepressant Discontinuation Symptoms: Prevalence, Impact, and Management

Antidepressant Discontinuation Symptoms: Prevalence, Impact, and Management

Broke On: Thursday, 06 June 2024 One in six people may experience antidepressant discontinuation symptoms (ADS) after prolonged use, including anxiety, depression, insomnia, and flu-like symptoms. The exact prevalence and impact of ADS are still debated. Factors increasing the risk include length of use, dosage, and specific antidepressants. Proper tapering under medical supervision can help minimize symptoms.
Olive Oil Consumption May Reduce Dementia-Related Death Risk by 28%: Harvard Study

Olive Oil Consumption May Reduce Dementia-Related Death Risk by 28%: Harvard Study

Broke On: Monday, 06 May 2024 New research from Harvard University suggests consuming at least 7 grams of olive oil daily may reduce dementia-related death risk by 28%. Olive oil's antioxidant compounds, monounsaturated fats, polyphenols, and vitamin E contribute to brain health protection and improved cardiovascular health.
Rise in Antidepressant Use Among Adolescents and Young Adults During COVID-19 Pandemic, Especially Girls

Rise in Antidepressant Use Among Adolescents and Young Adults During COVID-19 Pandemic, Especially Girls

Broke On: Monday, 26 February 2024 The COVID-19 pandemic has led to a sharp rise in antidepressant use among adolescents and young adults, particularly girls. A new study published in the journal Pediatrics found that antidepressant dispensing rose nearly 64% faster after March 2020 in young people aged 12 to 25. The increase was more pronounced among females, with a rate of rise of over twice as fast for girls aged between 13 and 17 years old compared to males in the same age group. This trend is consistent with multiple studies suggesting that rates of anxiety and depression increased during the pandemic.
PCOS Linked to Cognitive Decline in Midlife: Study Finds Women with Condition Score 11% Lower on Attention Ability Tests

PCOS Linked to Cognitive Decline in Midlife: Study Finds Women with Condition Score 11% Lower on Attention Ability Tests

Broke On: Wednesday, 31 January 2024 Recent studies have linked polycystic ovary syndrome (PCOS) with cognitive decline in midlife. Women with PCOS scored 11% lower on average compared to those without the condition when measuring attention ability and performed poorly on tests assessing memory, attention, and verbal abilities even after adjusting for age, race, and education. The exact causes of PCOS are still unknown but genetic factors may contribute to its development. It is important for women with PCOS to maintain a healthy lifestyle by having regular exercise routines that improve brain health such as cardiovascular exercises.
Combining PDE5is and Nitrates Increases Risk of Health Outcomes in Men with Cardiovascular Disease

Combining PDE5is and Nitrates Increases Risk of Health Outcomes in Men with Cardiovascular Disease

Broke On: Tuesday, 16 January 2024 A recent study published in the Journal of the American College of Cardiology found that taking phosphodiesterase type 5 inhibitors (PDE5is) along with nitrates for chest pain medication may increase the risk of negative health outcomes such as heart failure and early death in men with cardiovascular disease. Despite existing research and clinical guidelines discouraging simultaneous use of these medications, physicians are seeing an increase in requests for erectile dysfunction drugs from men with cardiovascular diseases.